IRIS Accounts Production v23.1.0.753 03739830 director 1.4.22 31.3.23 31.3.23 0 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure037398302022-03-31037398302023-03-31037398302022-04-012023-03-31037398302021-03-31037398302021-04-012022-03-31037398302022-03-3103739830ns16:EnglandWales2022-04-012023-03-3103739830ns15:PoundSterling2022-04-012023-03-3103739830ns11:Director12022-04-012023-03-3103739830ns11:PrivateLimitedCompanyLtd2022-04-012023-03-3103739830ns11:SmallEntities2022-04-012023-03-3103739830ns11:AuditExempt-NoAccountantsReport2022-04-012023-03-3103739830ns11:SmallCompaniesRegimeForDirectorsReport2022-04-012023-03-3103739830ns11:SmallCompaniesRegimeForAccounts2022-04-012023-03-3103739830ns11:FullAccounts2022-04-012023-03-3103739830ns11:RegisteredOffice2022-04-012023-03-3103739830ns6:CurrentFinancialInstruments2023-03-3103739830ns6:CurrentFinancialInstruments2022-03-3103739830ns6:ShareCapital2023-03-3103739830ns6:ShareCapital2022-03-3103739830ns6:RetainedEarningsAccumulatedLosses2023-03-3103739830ns6:RetainedEarningsAccumulatedLosses2022-03-3103739830ns6:NetGoodwill2022-04-012023-03-3103739830ns6:IntangibleAssetsOtherThanGoodwill2022-04-012023-03-3103739830ns6:LeaseholdImprovements2022-04-012023-03-3103739830ns6:MotorVehicles2022-04-012023-03-3103739830ns6:ComputerEquipment2022-04-012023-03-3103739830ns6:LeaseholdImprovements2022-03-3103739830ns6:MotorVehicles2022-03-3103739830ns6:ComputerEquipment2022-03-3103739830ns6:LeaseholdImprovements2023-03-3103739830ns6:MotorVehicles2023-03-3103739830ns6:ComputerEquipment2023-03-3103739830ns6:LeaseholdImprovements2022-03-3103739830ns6:MotorVehicles2022-03-3103739830ns6:ComputerEquipment2022-03-3103739830ns6:WithinOneYearns6:CurrentFinancialInstruments2023-03-3103739830ns6:WithinOneYearns6:CurrentFinancialInstruments2022-03-3103739830ns6:RetainedEarningsAccumulatedLosses2022-03-3103739830ns6:RetainedEarningsAccumulatedLosses2022-04-012023-03-31
REGISTERED NUMBER: 03739830 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 March 2023

for

Jephson Pharmacy Limited

Jephson Pharmacy Limited (Registered number: 03739830)






Contents of the Financial Statements
for the Year Ended 31 March 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


Jephson Pharmacy Limited

Company Information
for the Year Ended 31 March 2023







DIRECTOR: Davinder S Virdee





REGISTERED OFFICE: 17 David Road
Colnbrook
Slough
SL3 0DB





REGISTERED NUMBER: 03739830 (England and Wales)

Jephson Pharmacy Limited (Registered number: 03739830)

Balance Sheet
31 March 2023

31.3.23 31.3.22
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 66,409 67,093

CURRENT ASSETS
Stocks 5 170,440 150,280
Debtors 6 1,144,268 733,799
Cash at bank and in hand 58,709 194,202
1,373,417 1,078,281
CREDITORS
Amounts falling due within one year 7 667,158 451,849
NET CURRENT ASSETS 706,259 626,432
TOTAL ASSETS LESS CURRENT
LIABILITIES

772,668

693,525

CAPITAL AND RESERVES
Called up share capital 76 76
Retained earnings 8 772,592 693,449
772,668 693,525

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 28 March 2024 and were signed by:





Davinder S Virdee - Director


Jephson Pharmacy Limited (Registered number: 03739830)

Notes to the Financial Statements
for the Year Ended 31 March 2023

1. STATUTORY INFORMATION

Jephson Pharmacy Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business has been fully amortised in the current year.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Improvements to property - not provided
Motor vehicles - 25% on reducing balance
Computer equipment - 33% on cost

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Jephson Pharmacy Limited (Registered number: 03739830)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2023

2. ACCOUNTING POLICIES - continued

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2022 - 15 ).

4. TANGIBLE FIXED ASSETS
Improvements
to Motor Computer
property vehicles equipment Totals
£    £    £    £   
COST
At 1 April 2022
and 31 March 2023 64,506 9,323 9,114 82,943
DEPRECIATION
At 1 April 2022 - 7,203 8,647 15,850
Charge for year - 530 154 684
At 31 March 2023 - 7,733 8,801 16,534
NET BOOK VALUE
At 31 March 2023 64,506 1,590 313 66,409
At 31 March 2022 64,506 2,120 467 67,093

5. STOCKS
31.3.23 31.3.22
£    £   
Finished goods 170,440 150,280

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.23 31.3.22
£    £   
Trade debtors 43,446 47,322
Other debtors 931,725 640,449
VAT 64,228 31,277
Prepayments and accrued income 104,869 14,751
1,144,268 733,799

Jephson Pharmacy Limited (Registered number: 03739830)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2023

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.23 31.3.22
£    £   
Trade creditors 321,456 185,414
Tax 56,189 35,468
Social security and other taxes 107,660 72,053
Other creditors 69,366 82,543
Directors' current accounts 59,841 28,725
Accruals and deferred income 52,646 47,646
667,158 451,849

8. RESERVES
Retained
earnings
£   

At 1 April 2022 693,449
Profit for the year 79,143
At 31 March 2023 772,592

9. ULTIMATE CONTROLLING PARTY

The company is wholly owned subsidiary of Breakspear (Ashford) Limited, a company incorporated in England & Wales.